Omeros (OMER) Tax Provisions (2020 - 2026)

Omeros (OMER) posted Tax Provisions of $57000.0 for Q1 2026, down 99.27% sequentially from $7.9 million in Q4 2020.

Omeros (OMER) Tax Provisions (2020 - 2026) Analysis & Trends

Omeros has reported Tax Provisions for 2 years, with the latest figure at $57000.0 in Q1 2026.

Quarterly Tax Provisions changed N/A year-over-year to $57000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57000.0 (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, down 12.71% from the prior year.
Tax Provisions declined to $57000.0 in Q1 2026 per OMER's latest filing, from $7.9 million in the prior quarter.
Over five years, Tax Provisions peaked at $57000.0 in Q1 2026 and troughed at $57000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Omeros	1.24 Bn	1.24 Bn	27.73 Mn	29,000.00

Download Data